StockClub

SBFMW

SBFMWSunshine Biopharma, Inc.$ --
Sunshine Biopharma, Inc.

Sunshine Biopharma, Inc.

SBFMW

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2025FY2025 Q3
Revenue
9M USD
YoY +11.6%
Operating Income
-1M USD
YoY +1.8%
Net Income
-1M USD
YoY +26.2%
EPS
-0.19$
YoY +79.8%

Revenue

$27.7M
FY2023 Q4$24.1M
$24.1M
Q4
FY2024 Q1$7.5M
$7.5M
Q1
FY2024 Q2$16.8M
$16.8M
Q2
FY2024 Q3$25.3M
$25.3M
Q3
FY2024 Q4$34.9M
$34.9M
Q4
FY2025 Q1$8.9M
$8.9M
Q1
FY2025 Q2$18.3M
$18.3M
Q2
FY2025 Q3$27.7M
$27.7M
Q3
Actual
+$2.4M (+9.7%)

Net Income

$-3.8M
FY2023 Q4$-4.5M
$-4.5M
Q4
FY2024 Q1$-1.3M
$-1.3M
Q1
FY2024 Q2$-1.8M
$-1.8M
Q2
FY2024 Q3$-3M
$-3M
Q3
FY2024 Q4$-5.1M
$-5.1M
Q4
FY2025 Q1$-1.2M
$-1.2M
Q1
FY2025 Q2$-3M
$-3M
Q2
FY2025 Q3$-3.8M
$-3.8M
Q3
Actual
$-858,654 (-28.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:$21,121
FY2019
$21,121
FY2020
Actual:$71,410
FY2020
$71,410
FY2021
Actual:$228,426
FY2021
$228,426
FY2022
Actual:$4.3M
FY2022
$4.3M
FY2023BEAT
Actual:$24.1M
Est:$22.5M
FY2023BEAT
$24.1M
FY2024MISS
Actual:$34.9M
Est:$37.8M
FY2024MISS
$34.9M

Analyst Estimates